Global Octreotide Market Growth 2025-2031

The global Octreotide market size is predicted to grow from US$ 2.8 million in 2025 to US$ 2.3 million in 2031; it is expected to grow at a CAGR of -2.9% from 2025 to 2031.

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.

Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.

LP Information, Inc. (LPI) ' newest research report, the “Octreotide Industry Forecast” looks at past sales and reviews total world Octreotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Octreotide sales for 2025 through 2031. With Octreotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Octreotide industry.

This Insight Report provides a comprehensive analysis of the global Octreotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Octreotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Octreotide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Octreotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Octreotide.

This report presents a comprehensive overview, market shares, and growth opportunities of Octreotide market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Octreotide Injection

Octreotide Powder

Octreotide Microspheres

Segmentation by Application:

Treating Severe Diarrhea

Treating Acromegaly

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Novartis

Sun Pharmaceutical

Chengdu Tiantaishan pharmaceutical

Sinopharm A-Think Pharmaceuticals

Sihuan Pharmaceutical Holdings Group

Shanghai Soho-Yiming Pharmaceuticals

Yibin Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Octreotide market?

What factors are driving Octreotide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Octreotide market opportunities vary by end market size?

How does Octreotide break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.